Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Language
Publication year range
1.
Int. j. cardiovasc. sci. (Impr.) ; 36: e20220143, 2023. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1440288

ABSTRACT

Abstract Background Atrial fibrillation (AF) is the most common arrhythmia in patients with end-stage renal disease (ESRD). The coexistence of high thromboembolic and hemorrhagic risks, added to the lack of strong scientific evidence on the safety of anticoagulants in the setting of renal failure, makes this a clinically challenging situation. Objectives To describe the clinical-demographic profile and prevalence of AF in the population with ESRD undergoing dialysis. Secondary objectives include the assessment of thromboembolic (CHA2DS2VASC) and bleeding (HASBLED) risk scores. Methods Cross-sectional analytical-descriptive study, carried out between January and March 2020. Patients with ESRD were evaluated by means of a medical history questionnaire, physical examination, and 12-lead electrocardiogram. A chi-square (χ2) association test was applied to calculate association between clinical variables and AF, with a significance level of α = 0.05. Results This study evaluated 295 patients, most of whom were men (170), elderly (63, IQR 53-71), current smokers (130), with associated cardio-endocrine comorbidities. The prevalence of AF was 6.7% (20). Heart failure (HF) (χ2=15.417; p<0.001), age of 65 years or older (χ2=14.584; p<0.001), and anticoagulation (χ2=5.715; p<0.01) were associated with AF. The median CHA2DS2VASC and HASBLED was 4 and 3, respectively. Eight patients were taking warfarin and five were receiving apixaban. Conclusion The prevalence of AF in this study is similar to that reported in other published articles on the subject, and patients were at high risk for cardiovascular outcomes. Non-anticoagulation strategy was commonly adopted due to controversies in the literature as well as the absence of published randomized clinical trials.

2.
Rev. bras. cir. cardiovasc ; 37(5): 780-783, Sept.-Oct. 2022. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1407307

ABSTRACT

Abstract Coronary subclavian steal syndrome is an uncommon cause of angina in patients with a previous coronary artery bypass graft procedure. The patient had chest pain with the exertion of the left upper limb, difference in blood pressure between the left and right arm, occlusion at the ostium of the left subclavian artery. He underwent carotid subclavian bypass surgery that was successful in relieving symptoms. On the other hand, the patient had an embolic stroke related to the procedure and further assessment may be necessary.

3.
Braz J Cardiovasc Surg ; 37(5): 780-783, 2022 10 08.
Article in English | MEDLINE | ID: mdl-34673515

ABSTRACT

Coronary subclavian steal syndrome is an uncommon cause of angina in patients with a previous coronary artery bypass graft procedure. The patient had chest pain with the exertion of the left upper limb, difference in blood pressure between the left and right arm, occlusion at the ostium of the left subclavian artery. He underwent carotid subclavian bypass surgery that was successful in relieving symptoms. On the other hand, the patient had an embolic stroke related to the procedure and further assessment may be necessary.


Subject(s)
Coronary-Subclavian Steal Syndrome , Subclavian Steal Syndrome , Male , Humans , Coronary-Subclavian Steal Syndrome/diagnostic imaging , Coronary-Subclavian Steal Syndrome/surgery , Coronary-Subclavian Steal Syndrome/complications , Subclavian Steal Syndrome/diagnostic imaging , Subclavian Steal Syndrome/surgery , Coronary Artery Bypass/adverse effects , Subclavian Artery/diagnostic imaging , Subclavian Artery/surgery , Angina Pectoris/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...